Skip to main content

Manulife Mulfact CDN Smid Cap Idx ETF(MCSM-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Manulife Mulfact CDN Smid Cap Idx ETF up on Thursday (MCSM)

Automated Summaries - The Globe and Mail - Thu Mar 14, 4:01PM CDT

In market activity today, shares of Manulife Mulfact CDN Smid Cap Idx ETF opened at $37.29 and closed at $37.38. Intraday prices ranged from a low of $37.29 to a high of $37.41.

The price boosted 0.32 percent from the previous day's close of $37.26.

Today across North America, the TSX Composite closed 0.64% at 21970.11, the S&P 500 closed -0.19% at 5165.31, the Dow Jones Industrial Average closed 0.10% at 39043.32 and the Nasdaq Composite closed -0.54% at 16177.77.

Manulife Mulfact CDN Smid Cap Idx ETF traded under MCSM on the Toronto Stock Exchange (TSX).

A total of 659 shares was traded during the session, with total trades of 4. On average, Manulife Mulfact CDN Smid Cap Idx ETF has traded 2,292 shares in the last five days and 1,939 year-to-date.

The TSX overall saw 997 price advancers against 4,289 declines and 80 unchanged.

During the prior 52 weeks, MCSM.TO has traded as high as $37.44 (July 31,2023) and low as $33.93 (October 27,2023). Moreover, in the last 12 months, Manulife Mulfact CDN Smid Cap Idx ETF's shares have advanced 7.94 percent, while they have climbed 3.32% this year.

Following today's trading, Manulife Mulfact CDN Smid Cap Idx ETF has a market capitalization of $253.37 million on a float of 6,800 shares outstanding. Its annual EPS is $None.

Manulife Mulfact CDN Smid Cap Idx ETF is a None company headquartered in, None.

The Manulife Multifactor Canadian SMID Cap Index ETF seeks to track the performance of the John Hancock Dimensional Canadian SMID Cap Equity Index (CAD), before fees and expenses..

Currently, Manulife Mulfact CDN Smid Cap Idx ETF has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe